Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C Zimmerman
Comparison of Risk Stratification Tools in Predicting Outcomes of Patients With Higher-Risk Myelodysplastic Syndromes Treated With Azanucleosides
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
Role of BCL2L10 Methylation and TET2 Mutations in Higher Risk Myelodysplastic Syndromes Treated With 5-Azacytidine
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Systematic Literature Review of Treatment Options and Clinical Outcomes for Patients With Higher Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Improving Prognostic Tools for Patients With Myelodysplastic Syndromes
Mayo Clinic Proceedings
Medicine
Myelodysplastic Syndromes: 2018 Update on Diagnosis, Risk-Stratification and Management
American Journal of Hematology
Hematology
There’s Risk, and Then There’s RISK: The Latest Clinical Prognostic Risk Stratification Models in Myelodysplastic Syndromes
Current Hematologic Malignancy Reports
Cancer Research
Oncology
Hematology
Assessment of ATRX Expression in Patients With Myelodysplastic Syndromes Treated With Decitabine
Leukemia Research
Cancer Research
Oncology
Hematology
Long-Term Outcome of Immunosuppressive Therapy for Japanese Patients With Lower-Risk Myelodysplastic Syndromes
International Journal of Hematology
Hematology
Survival Advantage With Decitabine Versus Intensive Chemotherapy in Patients With Higher Risk Myelodysplastic Syndrome
Cancer
Cancer Research
Oncology
Cost-Effectiveness in Canada of Azacitidine for the Treatment of Higher-Risk Myelodysplastic Syndromes
Current Oncology
Oncology
